SCHEMBL5454059

SCHEMBL5454059

CC(=NO)c1ccc(Cl)cc1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.69
KMT2A Q03164 1/20 0.69
HSD17B10 Q99714 3/20 0.45
TSHR P16473 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP3A4 P08684 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
MGLL Q99685 1/20 0.42
ALOX15 P16050 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
SLC2A1 P11166 1/20 0.40
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
PLAU P00749 1/20 0.38
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5025769 1.00 MEN1 (0.69) MEN1KMT2AHSD17B10TSHRALDH1A1
SCHEMBL19142589 0.84 MEN1 (0.63) MEN1KMT2AHSD17B10TSHRALDH1A1
SCHEMBL4306902 0.82 KMT2A (1.00) MEN1KMT2AHSD17B10TSHRALDH1A1
SCHEMBL8809751 0.82 KMT2A (1.00) MEN1KMT2AHSD17B10TSHRALDH1A1
SCHEMBL4306904 0.82 KMT2A (1.00) MEN1KMT2AHSD17B10TSHRALDH1A1
SCHEMBL5704879 0.80 MEN1 (0.69) MEN1KMT2ACYP3A4ESR1ESR2
SCHEMBL3859431 0.79 ESR1 (0.56) MEN1KMT2ATSHRALDH1A1ESR1
SCHEMBL1656388 0.79 ESR1 (0.56) MEN1KMT2ATSHRALDH1A1ESR1
SCHEMBL1656386 0.79 ESR1 (0.56) MEN1KMT2ATSHRALDH1A1ESR1
SCHEMBL29156765 0.78 MEN1 (0.67) MEN1KMT2AHSD17B10ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 MEN1 614/4885KMT2A 1857/4885HSD17B10 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.